http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2412790-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1439c740593e72dc83c0eb17237bb01
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
filingDate 2001-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621f75ca215a89de801b931637c878c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d8379573316642aab4679675cbd6640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62cfb7f83bc902a83ffe4e418ff3d5c0
publicationDate 2002-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2412790-A1
titleOfInvention Liposomal antineoplastic drugs and uses thereof
abstract This invention relates to liposomal antineoplastic agents (e.g., camptothecin) compositions and methods of using such compositions for treating neoplasia and for inhibiting angiogenesis. The compositions and methods are useful for modulating the plasma circulation half-life of an active agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993914-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344552-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369597-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11318131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11052079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10980795-B2
priorityDate 2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6453725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID472335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124516887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426111618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415865207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426070748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743287

Total number of triples: 60.